HearingTracker
Industry news · Tinnitus← The news desk

✦ The Dispatch

Neuromod Adds Commercial Leaders to Support Expansion of Lenire Tinnitus Treatment

A dispatch from Hearing Health Matters — filed

Hand lifting a Lenire-branded over-ear headset beside a white Lenire controller unit and a tongue-tip stimulator on a marble surface.
✦ PlateHand lifting a Lenire-branded over-ear headset beside a white Lenire controller unit and a tongue-tip stimulator on a marble surface.

DUBLIN, IRELAND — Neuromod Devices has expanded its senior commercial leadership team with the appointment of Joe Ghiz as Chief Commercial Officer (CCO) and Shannon Basham as Vice President of Channel Development. The appointments come as Neuromod works to expand access to Lenire, its bimodal neuromodulation treatment for tinnitus, through ENT and audiology practices in the United States and other markets....

Continue reading at Hearing Health Matters

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

No actionable change to clinical practice; this is a business personnel announcement with no new clinical evidence for Lenire.

✦ Why It Matters ✦

Expanded commercial leadership at Neuromod could accelerate Lenire's market penetration, giving more audiologists and tinnitus clinics access to bimodal neuromodulation as a treatment option.

✦ Key Points ✦
  1. 01Joe Ghiz appointed Chief Commercial Officer at Neuromod Devices.
  2. 02Shannon Basham appointed VP of Channel Development.
  3. 03Both hires are aimed at broadening market access for the Lenire tinnitus device.
  4. 04Lenire uses bimodal stimulation (sound plus tongue stimulation) for tinnitus relief.
  5. 05No new clinical trial results or safety data accompany this announcement.
✦ Related stories ✦